Polivy (polatuzumab vedotin)

pCPA File Number: 21471
Negotiation Status:
Under consideration for negotiation
Indication(s):
Diffuse Large B-Cell Lymphoma (DLBCL)
Sponsor/Manufacturer:
HOFFMANN-LA ROCHE LIMITED
CADTH Project Number:
PC0227-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable